Growth Metrics

Merck (MRK) Long-Term Investments (2016 - 2025)

Merck (MRK) has disclosed Long-Term Investments for 17 consecutive years, with $1.1 billion as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Investments rose 240.55% to $1.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 billion, a 240.55% increase, with the full-year FY2024 number at $463.0 million, up 83.73% from a year prior.
  • Long-Term Investments was $1.1 billion for Q3 2025 at Merck, up from $774.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $1.3 billion in Q3 2023 to a low of $238.0 million in Q2 2022.
  • A 5-year average of $571.6 million and a median of $463.0 million in 2024 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: crashed 75.17% in 2023, then surged 240.55% in 2025.
  • Merck's Long-Term Investments stood at $370.0 million in 2021, then skyrocketed by 174.32% to $1.0 billion in 2022, then plummeted by 75.17% to $252.0 million in 2023, then surged by 83.73% to $463.0 million in 2024, then soared by 141.25% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Long-Term Investments are $1.1 billion (Q3 2025), $774.0 million (Q2 2025), and $616.0 million (Q1 2025).